Studies (first author, year of publication, AL measuring method) | Type of RVO | Number of patients with RVO/control eyes | Difference in AL between affected RVO and unaffected fellow eyes (mm) | Difference in AL between affected RVO and control eyes (mm) |
---|---|---|---|---|
Ariturk (1996) [9]† | BRVO | 41/66 | 0.10 | 0.33* |
Timmerman (1997) [10]† | BRVO | 24/24 | 0.04 | 0.6* |
Simons (1997) [11]† | BRVO | 36/36 | - | 0.07 |
Bandello (1998) [12]† | BRVO | 88/50 | - | 1.03 |
Kir (1998) [13]† | BRVO | 50/45 | 0.02 | 0.03 |
Cekic (1999) [14]† | BRVO | 27/17 | 0.13 | 0.37 |
Tsai (2003) [15]† | BRVO | 77/67 | 0.19* | 0.85* |
Goldstein (2004) [16]† | BRVO | 24 | 0.21* | - |
Mehdizadeh (2005) [17]† | BRVO | 18/18 | 0.25* | 1.25** |
Brown (1990) [18]† | CRVO | 24/44 | 0.03 | 0.67* |
Ariturk (1996) [9]† | CRVO | 17/66 | 0.36* | 0.97** |
Kir (1998) [13]† | CRVO | 39/45 | 0.07 | 0.10 |
Kir (1998) [13]† | HRVO | 13/45 | 0.15 | 0.19 |
Bandello (1998) [12]† | CRVO | 58/50 | - | 0.27 |
Cekic (1999) [14]† | CRVO | 19/25 | 0.62* | 0.95* |
Tsai (2003) [15]† | CRVO | 40/67 | 0.26 | 0.76* |
Mehdizadeh (2005) [17]† | CRVO | 18/18 | 0.52* | 1.06* |
Mirshahi (2005) [19]† | CRVO | 30/29 | 0.02 | 0.23 |
Moghimi (2007) [20]†† | CRVO | 29 | 0.07 | - |
Gupta (2010) [21]† | RVO | 25/25 | 0.83* | - |